Procalcitonin to guide antibiotic therapy in the ICU (Q26775450)

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Postoperative plasma concentrations of procalcitonin after different types of surgery

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Early systemic procalcitonin levels in patients with aneurysmal subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Procalcitonin after cardiac arrest - an indicator of severity of illness, ischemia-reperfusion injury and outcome

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

The value of procalcitonin at predicting the severity of acute pancreatitis and development of infected pancreatic necrosis: systematic review

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Evolution and significance of circulating procalcitonin levels compared with IL-6, TNFα and endotoxin levels early after thermal injury

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients.

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes.

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Procalcitonin increase in early identification of critically ill patients at high risk of mortality

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Systemic Inflammatory Response and Potential Prognostic Implications After Out-of-Hospital Cardiac Arrest: A Substudy of the Target Temperature Management Trial

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: A systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial*

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic dur

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis.

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue.

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

BAL neutrophils, serum procalcitonin, and C-reactive protein to predict bacterial infection in the immunocompromised host

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021

Clinical Experiences with a New Semi-Quantitative Solid Phase Immunoassay for Rapid Measurement of Procalcitonin

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2015.10.012

7 January 2021